Sycha, T, Kranz, G, Auff, E, Schnider, P. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature. J Neurol. 2004; 251 Suppl 1:I19-30.
Nixdorf, DR, Heo, G, Major, PW. Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. Pain. 2002; 99(3):465-73.
Guarda-Nardini, L, Manfredini, D, Salamone, M, Salmaso, L, Tonello, S, Ferronato, G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio : the journal of craniomandibular practice. 2008; 26(2):126-35.
von Lindern, JJ, Niederhagen, B, Berge, S, Appel, T. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2003; 61(7):774-8.
Kurtoglu, C, Gur, OH, Kurkcu, M, Sertdemir, Y, Guler-Uysal, F, Uysal, H. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2008; 66(8):1644-51.
Ernberg, M, Hedenberg-Magnusson, B, List, T, Svensson, P. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain. 2011; 152(9):1988-96.
Al-Moraissi, EA, Alradom, J, Aladashi, O, Goddard, G, Christidis, N. Needling therapies in the management of myofascial pain of the masticatory muscles: A network meta-analysis of randomised clinical trials. Journal of oral rehabilitation. 2020; 47(7):910-22.
Ahmed, S, Subramaniam, S, Sidhu, K, Khattab, S, Singh, D, Babineau, J, et al. Effect of Local Anesthetic Versus Botulinum Toxin-A Injections for Myofascial Pain Disorders: A Systematic Review and Meta-Analysis. The Clinical journal of pain. 2019; 35(4):353-67.
Khalifeh, M, Mehta, K, Varguise, N, Suarez-Durall, P, Enciso, R. Botulinum toxin type A for the treatment of head and neck chronic myofascial pain syndrome: A systematic review and meta-analysis. Journal of the American Dental Association (1939). 2016; 147(12):959-73.e1.
Soares, A, Andriolo, RB, Atallah, AN, da Silva, EM. Botulinum toxin for myofascial pain syndromes in adults. The Cochrane database of systematic reviews. 2014; (7):Cd007533.
Chen, YW, Chiu, YW, Chen, CY, Chuang, SK. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials. International journal of oral and maxillofacial surgery. 2015; 44(8):1018-26.
Patel, J, Cardoso, JA, Mehta, S. A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism. British dental journal. 2019; 226(9):667-72.
Awan, KH, Patil, S, Alamir, AWH, Maddur, N, Arakeri, G, Carrozzo, M, et al. Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2019; 48(3):192-200.
Thambar, S, Kulkarni, S, Armstrong, S, Nikolarakos, D. Botulinum toxin in the management of temporomandibular disorders: a systematic review. The British journal of oral & maxillofacial surgery. 2020; 58(5):508-19.